Standard InChI: InChI=1S/C18H17F3N4O2S/c19-18(20,21)11-3-1-10(2-4-11)13-5-6-14(24-13)16(27)25-15(7-22)17-23-8-12(9-26)28-17/h1-6,8,15,24,26H,7,9,22H2,(H,25,27)/t15-/m1/s1
1.Curreli F, Ahmed S, Benedict Victor SM, Iusupov IR, Belov DS, Markov PO, Kurkin AV, Altieri A, Debnath AK.. (2020) Preclinical Optimization of gp120 Entry Antagonists as anti-HIV-1 Agents with Improved Cytotoxicity and ADME Properties through Rational Design, Synthesis, and Antiviral Evaluation., 63 (4):[PMID:32031803][10.1021/acs.jmedchem.9b02149]
2.Curreli F,Belov DS,Kwon YD,Ramesh R,Furimsky AM,O'Loughlin K,Byrge PC,Iyer LV,Mirsalis JC,Kurkin AV,Altieri A,Debnath AK. (2018) Structure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120., 154 [PMID:29860061][10.1016/j.ejmech.2018.04.062]
3.Curreli F, Ahmed S, Benedict Victor SM, Iusupov IR, Spiridonov EA, Belov DS, Altieri A, Kurkin AV, Debnath AK.. (2021) Design, synthesis, and antiviral activity of a series of CD4-mimetic small-molecule HIV-1 entry inhibitors., 32 [PMID:33461144][10.1016/j.bmc.2021.116000]